The increasing incidence of neurological problems paralleled by technology advances are supporting high growth potential in the European neurological monitoring market.

Frost & Sullivan (www.healthcare.frost.com) finds that the European Neurological Monitoring Market earned revenues of $135.2 million in 2005 and estimates this to reach $175.3 million in 2012.

“Neurological monitoring is a technologically advanced market and is poised to revolutionise the monitoring of neurological parameters,” states Frost & Sullivan Research Analyst C.R. Hema Varshika. “Market participants have shifted their focus towards new applications, like long-term monitoring of conditions such as epilepsy and sleep disorders that will drive market growth.”

The rising incidence of epilepsy in developed nations and heightened awareness about sleep disorders coupled with the rapid rise of sleep labs and sleep clinics has greatly motivated and influenced the growth of the neurological monitoring market in such applications.

However, market saturation together with a stagnant competitive landscape is posing a serious challenge. The presence of well established participants is making it extremely difficult for newer companies to enter the market.

“In this market with rising health expenditures and an unstable economy, tactical and well calculated measures have to be taken to develop and promote one’s products,” cautions Ms. Varshika. “Product development initiatives need to be based on research in emerging areas and be supported by strategic marketing. Proactive alliances and tactical marketing plans followed by effective execution will enable expansion in market share.”